Oxford Covid Vaccine Trials To Be Conducted In India Soon; Other Big Stories
Trials for the coronavirus vaccine developed at the Oxford University will begin in India as soon as a license is procured, said the Indian firm partnering the researchers in the UK. The vaccine AZD1222 had a favourable response in the first phase of clinical trials. It did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.
-
A vaccine for Covid-19 developed by Oxford University and AstraZeneca was safe and produced an immune response in early-stage clinical trials, data showed on Monday, raising hopes that the world could soon find a way to stop the virus that has taken an unprecedented human and economic toll across the planet.
-
Officials of the Union health ministry had in early April blocked public disclosure of the names of 36 districts where researchers had found evidence of community transmission of the new coronavirus, three experts guiding India's pandemic response have said.
